RESUMO
Refractory materials exhibit high damage tolerance, which is attractive for the creation of nanoscale field-emission electronics and optoelectronics applications that require operation at high peak current densities and optical intensities. Recent results have demonstrated that the optical properties of titanium nitride, a refractory and CMOS-compatible plasmonic material, can be tuned by adding silicon and oxygen dopants. However, to fully leverage the potential of titanium (silicon oxy)nitride, a reliable and scalable fabrication process with few-nm precision is needed. In this work, we developed a fabrication process for producing engineered nanostructures with gaps between 10 and 15 nm, aspect ratios larger than 5 with almost 90° steep sidewalls. Using this process, we fabricated large-scale arrays of electrically-connected bow-tie nanoantennas with few-nm free-space gaps. We measured a typical variation of 4 nm in the average gap size. Using applied DC voltages and optical illumination, we tested the electronic and optoelectronic response of the devices, demonstrating sub-10 V tunneling operation across the free-space gaps, and quantum efficiency of up to 1 × 10-3at 1.2µm, which is comparable to a bulk silicon photodiode at the same wavelength and three orders of magnitude higher than with nearly identical gold devices. Tests demonstrated that the titanium silicon oxynitride nanostructures did not significantly degrade, exhibiting less than 5 nm of shrinking of the average gap dimensions over few-µm2areas after 10 h of operation. Our results will be useful for developing the next generation of robust and CMOS-compatible nanoscale devices for high-speed and low-power field-emission electronics and optoelectronics applications.
Assuntos
Antineoplásicos/uso terapêutico , Corioide/irrigação sanguínea , Interferon-alfa/uso terapêutico , Degeneração Macular/complicações , Neovascularização Patológica/terapia , Antineoplásicos/administração & dosagem , Eletrorretinografia , Angiofluoresceinografia , Seguimentos , Fóvea Central , Fundo de Olho , Humanos , Injeções , Interferon alfa-2 , Interferon-alfa/administração & dosagem , Degeneração Macular/fisiopatologia , Pessoa de Meia-Idade , Neovascularização Patológica/etiologia , Neovascularização Patológica/fisiopatologia , Projetos Piloto , Proteínas Recombinantes , Segurança , Acuidade Visual , Corpo VítreoAssuntos
Malformações Arteriovenosas/genética , Ataxia Telangiectasia/genética , Síndromes Neoplásicas Hereditárias/genética , Esclerose Tuberosa/genética , Doença de von Hippel-Lindau/genética , Animais , Malformações Arteriovenosas/diagnóstico , Ataxia Telangiectasia/diagnóstico , Feminino , Humanos , Masculino , Síndromes Neoplásicas Hereditárias/diagnóstico , Esclerose Tuberosa/diagnóstico , Doença de von Hippel-Lindau/diagnósticoRESUMO
OBJECTIVE: To investigate the toxicity of single doses of intravitreally administered interferon alpha-2b in the New Zealand white albino rabbit. INTERVENTIONS: One eye each of six rabbits received an intravitreal injection of 1000, 10,000, 100,000, 500,000, 1 million or 2 million units of interferon alpha-2b reconstituted in 0.1 mL of balanced salt solution. The fellow eye of the first three rabbits received an intravitreal injection of the same volume of balanced salt solution. OUTCOME MEASURES: Media opacities, toxic effects to the retina, optic nerve or other ocular structures. RESULTS: The injection of 2 million units of interferon alpha-2b elicited an immediate dense vitreous haze that largely cleared within 24 hours as well as numerous intraretinal hemorrhages that were no longer visible 7 days after injection. Histopathological study of this eye 14 days after injection showed a diffuse mixed inflammatory cell infiltrate with retinal vacuolation and ganglion cell dropout. In the remaining eyes, to dosages of 1 million units, the agent produced no clinically or pathologically evident toxic ocular effects. CONCLUSIONS: Interferon alpha-2b appears to be safe and well tolerated up to dosages of 1 million units.
Assuntos
Olho/efeitos dos fármacos , Interferon-alfa/efeitos adversos , Animais , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Olho/patologia , Injeções/métodos , Interferon alfa-2 , Interferon-alfa/administração & dosagem , Degeneração Macular/patologia , Nervo Óptico/efeitos dos fármacos , Nervo Óptico/patologia , Coelhos , Proteínas Recombinantes , Retina/efeitos dos fármacos , Retina/patologia , Hemorragia Retiniana/induzido quimicamente , Corpo Vítreo/efeitos dos fármacos , Corpo Vítreo/patologiaRESUMO
To attempt to differentiate the cells of origin in epiretinal membranes, cells were cultured from an idiopathic epiretinal membrane and an epiretinal membrane that formed after successful repair of a retinal detachment. The cells exhibited a variety of forms. When the cells from the idiopathic epiretinal membrane were incubated with melanin from donor eyes a population of small cells accumulated the pigment, but the large, flat cells did not. The epiretinal membrane was not composed of a single cell type. Although a population of cells exists within epiretinal membranes, no one cell type could be identified as the cell type of origin.
Assuntos
Macula Lutea/patologia , Retina/patologia , Idoso , Células Cultivadas , Angiofluoresceinografia , Fundo de Olho , Humanos , Masculino , Melaninas/metabolismo , Pessoa de Meia-Idade , Descolamento Retiniano/patologia , Descolamento Retiniano/cirurgia , VitrectomiaRESUMO
Reported herein are the cases of two patients who developed subretinal neovascularization at the margin of a retinochoroidal coloboma. Possible explanations for the occurrence of this previously unemphasized association are addressed.